Simplex Trading’s Ariad Pharmaceuticals Inc ARIA Stock Holding History

Simplex Trading’s Portfolio ARIA Stock Details ARIA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	–	Sell	-922	Closed	-$78K	–	7351
2016 Q4	$78K	Sell	922 -350	-28%	-$4.21K	﹤0.01%	1752
2016 Q3	$84K	Sell	1,272 -785	-38%	-$7.88K	0.01%	1677
2016 Q2	$257K	Buy	2,057 +1,521	+284%	+$11.4K	0.02%	859
2016 Q1	$89K	Buy	536 +338	+171%	+$1.89K	0.01%	1461
2015 Q4	$47K	Buy	198 +93	+89%	+$610	﹤0.01%	1970
2015 Q3	$31K	Sell	105 -8	-7%	-$62	﹤0.01%	2377
2015 Q2	$25K	Buy	+113	New	+$999	﹤0.01%	2282
2015 Q1	–	Sell	-74	Closed	-$18K	–	6088
2014 Q4	$18K	Buy	+74	New	+$463	﹤0.01%	2162

Other funds holding ARIA

FPF

FNY Partners Fund New York $185M AUM 32.57% 1-Year Est. Return

Simplex Trading's ARIA Position: Q1 2017 in Review

Simplex Trading sold out of Ariad Pharmaceuticals Inc (ARIA) in Q1 2017, closing a stake of 38,420 shares — an estimated $477K sold.

Simplex Trading first reported a position in ARIA in Q1 2015 and held it in 6 quarters. The position peaked at $1.31M in Q2 2016. 1 fund tracked by Wall St. Rank holds ARIA as of Q1 2017.

Simplex Trading reported no remaining Ariad Pharmaceuticals Inc position as of Q1 2017 after selling out during the quarter.
Simplex Trading sold 38,420 Ariad Pharmaceuticals Inc shares in Q1 2017, an estimated $477K.
Simplex Trading first reported a position in Ariad Pharmaceuticals Inc in Q1 2015 and held it in 6 quarters.
Simplex Trading's Ariad Pharmaceuticals Inc position peaked at $1.31M in Q2 2016.
1 fund tracked by Wall St. Rank held Ariad Pharmaceuticals Inc as of Q1 2017.

Based on Simplex Trading's 13F filing for Q1 2017, filed 21 Apr 2017.